Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise Dec 28, 2023 2:00 pm EST
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise Dec 27, 2023 9:10 am EST
Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting Dec 4, 2023 7:02 am EST
Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn Injuries Nov 30, 2023 7:00 am EST
Trevena Reports Favorable TRV045 Topline Safety and Tolerability Data from Proof-of-Concept Studies Oct 16, 2023 7:00 am EDT
Trevena Announces Completion of Initial Analysis of OLINVYK Continuous Respiratory Monitoring Data from VOLITION Study and Presentation at American Society of Anesthesiologists Conference Oct 2, 2023 7:00 am EDT